DMKPQ (DMK Pharmaceuticals) Shiller PE Ratio: (As of Sep. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DMKPQ DMK Pharmaceuticals Corp DMKPQ
16 GF Score
Price $0.00
View Full Analysis

What is DMK Pharmaceuticals Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


DMK Pharmaceuticals  (OTCPK:DMKPQ) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


DMK Pharmaceuticals Shiller PE Ratio Related Terms


DMK Pharmaceuticals Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for DMK Pharmaceuticals's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DMK Pharmaceuticals Shiller PE Ratio Chart

DMK Pharmaceuticals Annual Data
Trend Mar13 Mar14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

DMK Pharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

DMKPQ vs CNNC, THCT, VFRM: Shiller PE Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, DMK Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DMK Pharmaceuticals Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DMK Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where DMK Pharmaceuticals's Shiller PE Ratio falls into.


DMKPQ
16GF Score
DMK Pharmaceuticals Corp DMKPQ
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DMK Pharmaceuticals Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

DMK Pharmaceuticals's E10 for the quarter that ended in Sep. 2023 is calculated as:

For example, DMK Pharmaceuticals's adjusted earnings per share data for the three months ended in Sep. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-0.2/307.7890*307.7890
=-0.200

Current CPI (Sep. 2023) = 307.7890.

DMK Pharmaceuticals Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201312 -57.400 233.049 -75.808
201403 -12.600 236.293 -16.412
201406 -18.900 238.343 -24.407
201409 -14.000 238.031 -18.103
201412 -28.700 234.812 -37.620
201503 -22.400 236.119 -29.199
201506 -18.900 238.638 -24.377
201509 -16.800 237.945 -21.731
201512 -18.900 236.525 -24.594
201603 -33.600 238.132 -43.428
201606 -25.900 241.018 -33.075
201609 -28.700 241.428 -36.589
201612 4.200 241.432 5.354
201703 -18.200 243.801 -22.977
201706 -13.300 244.955 -16.712
201709 -14.700 246.819 -18.331
201712 -16.800 246.524 -20.975
201803 -16.100 249.554 -19.857
201806 -20.300 251.989 -24.795
201809 -14.700 252.439 -17.923
201812 -19.600 251.233 -24.012
201903 -13.300 254.202 -16.104
201906 -11.200 256.143 -13.458
201909 -8.400 256.759 -10.069
201912 -3.500 256.974 -4.192
202003 -7.700 258.115 -9.182
202006 -12.600 257.797 -15.043
202009 -10.500 260.280 -12.417
202012 -14.000 260.474 -16.543
202103 -8.400 264.877 -9.761
202106 -4.200 271.696 -4.758
202109 -5.600 274.310 -6.283
202112 -4.200 278.802 -4.637
202203 -4.900 287.504 -5.246
202206 -3.920 296.311 -4.072
202209 -2.050 296.808 -2.126
202212 -1.780 296.797 -1.846
202303 -4.200 301.836 -4.283
202306 -3.400 305.109 -3.430
202309 -0.200 307.789 -0.200

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


DMK Pharmaceuticals Business Description

Address 11682 El Camino Real, Suite 300, San Diego, CA, USA, 92130
DMK Pharmaceuticals Corp Formerly Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease. Its products and product candidates in the allergy, respiratory, and opioid overdose markets include SYMJEPI (epinephrine) Injection 0.3mg and Injection 0.15mg for use in the emergency treatment of acute allergic reactions, including anaphylaxis; a naloxone injection product candidate, ZIMHI, based on the approved Symject injection device and intended for the treatment of opioid overdose; Tempol, an investigational drug; and a Beclomethasone metered dose inhaler product candidate (APC-400) intended for the treatment of Covid-19.
16GF Score

Get the complete analysis for DMKPQ

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price